Ozempic and Wegovy linked to rare risk of sudden vision loss

· Science

Popular diabetes and weight-loss drugs such as Ozempic and Wegovy have been linked to a slightly increased risk of a rare condition that can cause sudden, potentially permanent vision loss, according to Rutgers researchers. Although the risk remains very low, the team says the findings warrant attention as millions of people turn to GLP-1 medications. The signal concerns a rare ocular condition, and the study does not establish that the drugs cause it. The finding adds to the growing list of side effects being monitored as GLP-1 use expands rapidly for both diabetes and obesity treatment, and it may prompt closer ophthalmological monitoring for some patients.

Why it matters：GLP-1 drugs are being prescribed at massive scale worldwide, so any new safety signal, even a rare one, feeds into regulatory review, prescribing guidance and pharmacovigilance.

Key points

  • Rutgers researchers reported a slightly increased risk
  • The condition can cause sudden, potentially permanent vision loss
  • The risk remains very low but researchers say it warrants attention

Sources (original reporting)

More stories from this day